Loading
Houston surgeon who chaired the melanoma expert panel for the eighth edition of the AJCC staging system, the classification doctors use to describe how far a melanoma has spread.
Jeffrey Gershenwald is a surgical oncologist at MD Anderson Cancer Center. He chaired the American Joint Committee on Cancer melanoma expert panel and was first author of the 2017 CA: A Cancer Journal for Clinicians paper presenting the eighth-edition melanoma staging system, which refined the T, N and M categories using data from more than 46,000 patients. He also studies sentinel node biopsy and the molecular biology of melanoma progression.
| Title | Journal | Year |
|---|---|---|
| Melanoma staging: evidence-based changes in the AJCC eighth edition cancer staging manual | CA: A Cancer Journal for Clinicians | 2017 |
Shares Stage IIB and IIC melanoma, Stage III melanoma (after surgery), Melanoma and the tag melanoma.
Shares Stage IIB and IIC melanoma, Stage III melanoma (after surgery), Melanoma.
Shares Melanoma and the tags melanoma, surgery.
Shares MD Anderson Cancer Center, Melanoma and the tag melanoma.
Shares Melanoma and the tags melanoma, surgery.
Shares the tags surgery, staging.
Shares Stage IIB and IIC melanoma, Melanoma and the tag melanoma.
Shares MD Anderson Cancer Center and the tag surgery.